On Friday, DryShips Inc. (NASDAQ:DRYS)’s shares declined -0.58% to $0.723.
DryShips Inc. (NASDAQ:DRYS) declared that Ocean Rig has launched an offering of its common stock, par value $0.01 per share. As part of this offering, George Economou, our Chairman, President and Chief Executive Officer, has indicated his intention to purchase, at the public offering price, a number of common shares that maintains his direct ownership in Ocean Rig, representing about five percent of its common stock.
Clarksons Platou Securities, Inc., Pareto Securities Inc. and Seaport Global Securities LLC are acting as joint lead managers, joint bookrunners and placement agents in the offering. Clarksons Platou Securities AS and Pareto Securities AS are acting as placement agents. Clarksons Platou Securities AS and Pareto Securities AS are not U.S. registered broker-dealers and to the extent that this offering is made within the United States, their activities will be effected only to the extent permitted by Rule 15a-6 of the Securities Exchange Act of 1934, as amended. Ocean Rig intends to use the net proceeds from the offering for working capital and general corporate purposes, counting the acquisition of drilling rigs.
DryShips Inc. provides ocean transportation services for drybulk and petroleum cargoes, and offshore deepwater drilling services. The company operates through Drybulk, Tanker, and Drilling segments. The Drybulk segment provides drybulk commodities transportation services for the steel, electric utility, construction, and agri-food industries. The Drilling segment offers ultra deep water drilling services.
DSW Inc. (NYSE:DSW)’s shares dropped -0.25% to $35.69.
DSW Inc. (DSW) will be giving back to the community through its Shoe Lovers Care Leave Your Mark program for the fourth time since 2013. Shoe Lovers Care Leave Your Mark enables DSW associates to nominate non-profits that make an impression on their lives for a chance to receive a $75,000 donation from DSW.
DSW associates nationwide were encouraged to nominate a local or national cause dear to their hearts. After internally reviewing the applications, DSW has selected 5 local and 3 national finalists to compete for the $75,000 donation. The finalists are: Association for Women in Science – Massachusetts Chapter; Brother Wolf Animal Rescue; Colon Cancer Alliance; Darkness to Light; Fisher House Foundation; The Foundation for New Education Initiatives, Inc.; Village Family Services; and YWCA Columbus.
DSW Inc., together with its auxiliaries, operates as a branded footwear and accessories retailer in the United States. The company operates through two segments, DSW and Associated Business Group. It offers dresses, casual and athletic footwear, and accessories under various brands for women, men, and kids. The company also provides handbags, hosiery, jewelry, and other accessories.
At the end of Friday’s trade, Lions Gate Entertainment Corp. (USA) (NYSE:LGF)‘s shares surged 0.80% to $35.40.
Aaron’s a wholly owned partner of Lions Gate Entertainment Corp. (USA) (LGF). Aaron’s, Inc., (AAN), a leading lease-to-own specialty retailer that offers flexible payment options for furniture, electronics and appliances, in partnership with “The Wendy Williams Show,” surprised Philadelphia resident Renea Harrington and her family with a brand new tech-ready bedroom suite as a part of the second annual “Win a Room in June” contest.
The Harrington couple is the first of four deserving families to receive a “Win a Room in June” contest prize package. The contest will continue for the remainder of June with three additional winners receiving room makeovers for their Living Room, Dining/Kitchen/Laundry Room and Kids’ Bedrooms.
Harrington and her husband have been married for six years, have two daughters and they are expecting a baby in July. The couple moved into their home in September 2014 and have focused their extra income on their family instead of on purchasing furniture for themselves. Now the couple will have a place to relax after a long day of work. Their new Ian Bedroom group comprises a queen bed, dresser, mirror, chest, and nightstand, all in a rich, espresso finish with silver burnished bar pull hardware and raised bases on slim feet. The Harrington family will receive a new Simmons Beautyrest® Brisben II Mattress, and their bedroom will be tech-ready with a LG® 50″ Smart LED TV, a LG® 300W Wireless Soundbar and a Dell® 11″ Touchscreen 2 in 1 Laptop.
In addition to the room makeovers, the Harringtons received round-trip air transportation for two to New York to attend a taping of “The Wendy Williams Show,” hotel accommodations for one night and ground transportation to the show.
Lions Gate Entertainment Corp. engages in motion picture production and distribution, television programming and syndication, home entertainment, family entertainment, digital distribution, channel platforms, and international distribution and sales activities. The company operates through two segments, Motion Pictures and Television Production.
he Medicines Company (NASDAQ:MDCO), ended its Friday’s trading session with 0.47% gain, and closed at $29.70.
he Medicines Company (MDCO) declared Phase 1 results for ABP-700, a novel, positive allosteric modulator of the GABAA receptor presently being developed for general anesthesia and procedural sedation. The results were presented at the 2015 Annual Dutch Society of Anesthesiology Conference in Maastricht, Netherlands.
The first-in-human, double-blind, placebo-controlled study in 60 subjects was designed to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ABP-700 after single ascending intravenous bolus doses. Study results showed linearly dose proportional pharmacokinetics and pharmacodynamic effects which were rapidly reversible, comprising with pre-clinical animal studies. Adverse events were mild with the exception of one subject with moderate tachycardia. No serious adverse events were stated.
The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
